Yes, PAX3 can serve as a biomarker for certain cancers. The presence of the PAX3-FOXO1 fusion gene is a diagnostic marker for ARMS. Elevated levels of PAX3 expression are also being explored as potential biomarkers for melanoma and other cancers. Detecting these markers can aid in early diagnosis, prognosis, and treatment planning.